The simulator also controls the strength of exhalations, meaning that the team could investigate how this and the size of nasal airways affects aerosol cloud dispersion. During their experiments, ...
Hosted on MSN11d
Kenox and Lactiga partner on sIgA therapies for immunodeficiencyfocuses on pharma aerosol product development, which includes a range of inhalers and sprays. These encompass soft mist ...
Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients: Princeton, New Jersey Wednesday, March 12, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results